An explainable AI approach for mapping multivariate regional brain age and clinical severity patterns in Alzheimer’s disease

Age is a significant risk factor for mild cognitive impairment (MCI) and Alzheimer's disease (AD) and identifying brain age patterns is critical for comprehending the normal aging and MCI/AD processes. Prior studies have widely established the univariate relationships between brain regions and age, while multivariate associations remain largely unexplored. Herein, various artificial intelligence (AI) models were used to perform brain age prediction using an MRI dataset (<i>n</i> = 825). The optimal AI model was then integrated with the feature importance methods, namely Shapley additive explanations (SHAP), local interpretable model-agnostic explanations, and layer-wise relevance propagation, to identify the significant multivariate brain regions hierarchically involved in this prediction. Our results showed that the deep learning model (referred to as AgeNet) outperformed conventional machine learning models for brain age prediction, and that AgeNet integrated with SHAP (referred to as AgeNet-SHAP) identified all ground-truth perturbed regions as key predictors of brain age in semi-simulation, demonstrating the validity of our methodology. In the experimental dataset, when compared to cognitively normal (CN) participants, MCI exhibited moderate differences in brain regions, whereas AD showed highly robust and widely distributed regional differences. Individualized AgeNet-SHAP regional features further showed associations with clinical severity scores in the AD continuum. These results collectively facilitate data-driven explainable AI approaches for disease progression, diagnostics, prognostics, and personalized medicine efforts.

Authors

Institutions

Publication Details

Journal
Biology Methods and Protocols
Published
2025-01-01
DOI
https://doi.org/10.1093/biomethods/bpaf051
Primary Topic
Machine Learning in Healthcare
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An explainable AI approach for mapping multivariate regional brain age and clinical severity patterns in Alzheimer’s disease

Taslim Murad, Ganesh B. Chand, Deepa S. Thakuri, Hui-Yuan Miao et al.
Biology Methods and Protocols
Machine Learning in Healthcare
article

An explainable AI approach for mapping multivariate regional brain age and clinical severity patterns in Alzheimer’s disease

Taslim Murad, Ganesh B. Chand, Deepa S. Thakuri, Hui-Yuan Miao, Gauri Darekar
article en

Abstract

Age is a significant risk factor for mild cognitive impairment (MCI) and Alzheimer's disease (AD) and identifying brain age patterns is critical for comprehending the normal aging and MCI/AD processes. Prior studies have widely established the univariate relationships between brain regions and age, while multivariate associations remain largely unexplored. Herein, various artificial intelligence (AI) models were used to perform brain age prediction using an MRI dataset (<i>n</i> = 825). The optimal AI model was then integrated with the feature importance methods, namely Shapley additive explanations (SHAP), local interpretable model-agnostic explanations, and layer-wise relevance propagation, to identify the significant multivariate brain regions hierarchically involved in this prediction. Our results showed that the deep learning model (referred to as AgeNet) outperformed conventional machine learning models for brain age prediction, and that AgeNet integrated with SHAP (referred to as AgeNet-SHAP) identified all ground-truth perturbed regions as key predictors of brain age in semi-simulation, demonstrating the validity of our methodology. In the experimental dataset, when compared to cognitively normal (CN) participants, MCI exhibited moderate differences in brain regions, whereas AD showed highly robust and widely distributed regional differences. Individualized AgeNet-SHAP regional features further showed associations with clinical severity scores in the AD continuum. These results collectively facilitate data-driven explainable AI approaches for disease progression, diagnostics, prognostics, and personalized medicine efforts.

Biology Methods and ProtocolsVol. 10(1)
Washington University in St. Louis (US), Mallinckrodt (United States) (US), Alzheimer’s Disease Neuroimaging Initiative (US), Hope Center for Neurological Disorders (US), University of Missouri (US)
U.S. Department of Defense, Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Biogen, Meso Scale Diagnostics, Washington University in St. Louis, BioClinica, Novartis Pharmaceuticals Corporation, Eisai, Servier, H. Lundbeck A/S, IXICO, National Institutes of Health, Genentech, Canadian Institutes of Health Research
Openalex Percentile: Top 89%
Machine Learning in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.